Product Information

RAMIPRIL 2.5 MG CAPSULE is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0494 per EA under NDC 57237022301. Its NADAC has been published 484 times since Aug 9, 2017.

FDA first approved this application on Jun 8, 2011. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RAMIPRIL 2.5 MG CAPSULE

Ramipril
$0.0494per EA

Strength

2.5 mg/1

NDC

57237022301

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

RAMIPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA091604

FDA Approved

6/8/2011

TE Code

AB

On Market Since

6/8/2011

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for RAMIPRIL 2.5 MG CAPSULE has been published 484 times since Aug 9, 2017, and over the history we have for it it has declined 32.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0494 per EA
All-time high$0.0824 (Nov 15, 2017)
All-time low$0.0425 (May 22, 2024)
52-week high$0.0578
52-week low$0.0460
Median price$0.0633
Average price$0.0633
Largest weekly change+29.9% (May 22, 2019)
Weeks tracked484
Tracking sinceAug 9, 2017

Price History

1W

0.0%

1M

+4.4%

3M

+6.1%

6M

-9.3%

1Y

-12.6%

3Y

-19.0%

5Y

-30.7%

All

-32.8%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RAMIPRIL 2.5 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for RAMIPRIL 2.5 MG CAPSULE, manufactured by Rising Pharma Holdings Inc., is $0.0494 per EA (NDC 57237022301), effective Nov 11, 2026.

How has the price of RAMIPRIL 2.5 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for RAMIPRIL 2.5 MG CAPSULE has declined 32.8%. It has been tracked across 484 weekly CMS publications since Aug 9, 2017.

What are the highest and lowest recorded NADAC prices for RAMIPRIL 2.5 MG CAPSULE?

Since Aug 9, 2017, the NADAC for RAMIPRIL 2.5 MG CAPSULE has ranged from a low of $0.0425 (May 22, 2024) to a high of $0.0824 (Nov 15, 2017), with a median of $0.0633 per EA.

Are there cheaper alternatives to RAMIPRIL 2.5 MG CAPSULE?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RAMIPRIL 2.5 MG CAPSULE, is $0.0460 per EA — about 7% below RAMIPRIL 2.5 MG CAPSULE.

Who manufactures RAMIPRIL 2.5 MG CAPSULE?

RAMIPRIL 2.5 MG CAPSULE (NDC 57237022301) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.